Theravance Biopharma logo
Theravance Biopharma
TBPH | NASDAQ
Chart Builder DCF Calculator
$17.03
$0.00 (0.00%)
At close: Sep 23, 2026, 4:00 PM ET

Theravance Biopharma Income Statement

Income statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
107.46M 64.38M 57.42M 51.35M 55.31M 71.86M
5.52M 37.64M 40.62M 63.39M 193.66M –
101.95M 26.74M 16.8M -12.05M -138.35M 71.86M
-13.25M -46.95M -56.04M -91.96M -257.78M -297.63M
– 4.88M 9.12M 8.55M 1.11M 4.44M
129.25M -44.61M -49.27M -92.82M -265.22M -303.34M
105.9M -56.42M -55.19M 872.13M -199.43M -278.02M
73.65M 69.17M 70.45M 67.07M 99.3M 108.53M
37.41M 38.05M 46.34M 70.07M 201.55M 260.95M
4.13M -33.54M -43.96M -57.24M -181.41M –
115.2M 73.69M 72.84M 79.91M 119.44M 369.48M
2.46M 2.55M 2.35M 6.37M 8.55M 8.55M
– 4.3M 5.1M 8M – –
120.71M 111.33M 113.46M 143.3M 313.1M 369.48M
23.35M 11.8M 5.92M 9K -151K -8.52M
50.32M 48.85M 55.3M 73.59M 69.46M 62.35M
51.51M 48.85M 55.3M 73.59M 69.46M 62.35M
2.10 -1.15 -1 -1.26 -2.87 -4.46
2.06 -1.15 -1 -1.26 -2.87 -4.46
137.22M -38.45M -51.65M -76.08M -232.83M -287.82M
131.71M -42.07M -53.65M -79.12M -237.64M -294.8M
5.52M 3.62M 2M 3.04M 4.81M 6.97M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.